, and until 2005, the geographical distribution of these enzymes in K. pneumoniae, both KPC-2 and KPC-3, was limited to the eastern United States (1, 12, 15) . In the New York area, KPC-producing strains have become a frequently-encountered nosocomial pathogen (2, 4) . The first case of KPC-producing K.
pneumoniae outside the US occurred in France where a patient who had been hospitalized in NY carried the strain with him (9). KPC-producing K. pneumoniae were reported since then from Israel (6), Colombia (13), China (14) , and Greece (8).
Carbapenem resistance in Klebsiella pneumoniae carrying bla KPC-2 was first observed in Tel Aviv Sourasky Medical Center in late 2005. In February 2006, we noted a sharp increase in bla KPC -carrying carbapenem-resistant K. pneumoniae strains in our hospital, mainly possessing bla KPC-3 (6). These extensively drug resistant (XDR) isolates caused difficult-to-treat infections and had an adverse impact on patients' outcomes (11). Our finding of the occurrence of closely related K. pneumoniae strains carrying bla KPC-3 on different plasmids in two continents is intriguing.
Despite infection control efforts that limited the spread of KPC-2 producing clones of
This report on international occurrence of a clone of XDR bla KPC-3 -producing K.
pneumoniae which has caused outbreaks in the US and Israel, emphasizes the potential for transmission of highly resistant Gram negative pathogens that are difficult and in some cases, impossible, to treat with currently available antimicrobial agents. This situation is exacerbated by the lack of novel agents in the antimicrobial pipeline to treat these pathogens. Our finding of similar strains in the US and Israel raises the possibility of a clonal XDR strain of K. pneumoniae, akin to what has been described for the 300.0114 strain of MRSA (5) and the NAP1/027 strain of C. difficile (7). This issue will require further investigation, but may help inform future studies directed at characterizing the molecular mechanisms, environmental factors, and selection pressures which promote the spread of this XDR hyper-epidemic strain. In the meantime, currently established infection control measures such as hand hygiene, isolation precautions and judicious antimicrobial use, should be employed throughout the world to limit the emergence and transmission of KPC-producing organisms. 
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